- $209.92bn
- $232.60bn
- $45.81bn
- 85
- 26
- 60
- 58
REG - AstraZeneca PLC - 1st Quarter Results
AnnouncementREG - AstraZeneca PLC - Director Declaration
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Update to arrangements with Sobi and Sanofi
AnnouncementREG - AstraZeneca PLC - Lynparza + Imfinzi met endpoint in ovarian cancer
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Ultomiris recommended for NMOSD EU approval
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - AstraZeneca completes KYM agreement for CMG901
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementREG - AstraZeneca PLC - Imfinzi improved EFS in resectable lung cancer
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Enhertu DESTINY-PanTumor02 shows positive results
AnnouncementREG - Stock Exch Notice - Admission to Trading - 03/03/2023
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca prices a $2.25bn bond offering
Announcement